Chargement en cours...
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
BACKGROUND: The objective of this study is to indicate the role of urokinase plasminogen activator receptor (uPAR), soluble uPAR (suPAR), and β1 integrin in tumor growth and invasion of lymph nodes from Hodgkin's lymphoma (HL) patients. MATERIALS AND METHODS: In this study, 25 lymph nodes from...
Enregistré dans:
| Publié dans: | Adv Biomed Res |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590394/ https://ncbi.nlm.nih.gov/pubmed/28904936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2277-9175.213668 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|